119th Congress · introduced in the House · Jun 27, 2025
Treat and Reduce Obesity Act of 2025
Official title from Congress.gov
Latest action (Jun 27, 2025): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Jun 27, 2025)
Treat and Reduce Obesity Act of 2025
This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner.
The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
49 citations; showing the 25 most recently posted.
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Pharmacy
$3,010,000
Spent on own lobbying
…vid - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. "Buddy" - PBM contract…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR PATIENT ACCESS · lobbying firm or registrant: ALLIANCE FOR PATIENT ACCESS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$20,000
Spent on own lobbying
S. 1973 / H.R. 4231 Treat and Reduce Obesity Act of 2025 S. 864 / H.R. 6423HELP Copays Act H.R.4317 - PBM Reform Act of 2025 COPD awareness/funding Biomarker testing coverage S. 3…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION) · lobbying firm or registrant: ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$150,000
Spent on own lobbying
Medical Nutrition Therapy Act (H.R.6199; S.3934) Expanding Access to Diabetes Self-Management Training Act (H.R.3826, S.1925) Treat and Reduce Obesity Act (H.R.4231/S.1973) Medically Tailored Home-Delivered Meals Demonstration Pilot Act (HR.5753, S.2834) CONNECT for Health Act (H.R. 4206/S. 1261)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELI LILLY AND COMPANY FKA LILLY USA, LLC · lobbying firm or registrant: FORBES-TATE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…edicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVO NORDISK, INC. · lobbying firm or registrant: ARNOLD & PORTER KAYE SCHOLER LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$80,000
Paid to lobbying firm
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2025 (H.R. 4231 / S. 1973).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL KIDNEY FOUNDATION · lobbying firm or registrant: NATIONAL KIDNEY FOUNDATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$80,000
Spent on own lobbying
…efit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION) · lobbying firm or registrant: ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$154,615
Spent on own lobbying
Medical Nutrition Therapy Act (H.R.6199; S.3934) Expanding Access to Diabetes Self-Management Training Act (H.R.3826, S.1925) Treat and Reduce Obesity Act (H.R.4231/S.1973) Medically Tailored Home-Delivered Meals Demonstration Pilot Act (HR.5753, S.2834) CONNECT for Health Act (H.R. 4206/S. 1261)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$3,010,000
Spent on own lobbying
…vid - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contractin…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELI LILLY AND COMPANY FKA LILLY USA, LLC · lobbying firm or registrant: FORBES-TATE
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…edicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR PATIENT ACCESS · lobbying firm or registrant: ALLIANCE FOR PATIENT ACCESS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$20,000
Spent on own lobbying
S. 1973 / H.R. 4231 Treat and Reduce Obesity Act of 2025 S. 864 / H.R. 6423HELP Copays Act H.R.4317 - PBM Reform Act of 2025 COPD awareness/funding Biomarker testing coverage S. 3…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CURRAX PHARMACEUTICALS LLC · lobbying firm or registrant: DLA PIPER LLP (US)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Pharmacy
$50,000
Paid to lobbying firm
Legislative and regulatory policies and proposals related to obesity treatment. Drug compounding safety. H.R. 4231/S. 1973, Treat and Reduce Obesity Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVO NORDISK, INC. · lobbying firm or registrant: ARNOLD & PORTER KAYE SCHOLER LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Medicare/Medicaid
$70,000
Paid to lobbying firm
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2025 (H.R. 4231 / S. 1973).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL KIDNEY FOUNDATION · lobbying firm or registrant: NATIONAL KIDNEY FOUNDATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 9, 2026 · issue area: Medicare/Medicaid
$80,000
Spent on own lobbying
…Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Sup…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 24, 2026 · issue area: Medicare/Medicaid
$24,000
Paid to lobbying firm
…d Social Service Workers Act H.R. 2586, Reentry Act of 2025 H.R. 3108/S. 1535, Rural Patient Monitoring Access Act H.R. 3684, Save Americas Rural Hospitals Act H.R. 4231/S. 1973, Treat and Reduce Obesity Act H.R. 4619, Medicare Mental Health Inpatient Equity Act of 2025 H.R. 4773/S. 3350, ACO Assignment Improvement Act of 2025…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GERONTOLOGICAL SOCIETY OF AMERICA · lobbying firm or registrant: NVG, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Apr 21, 2026 · issue area: Medicare/Medicaid
$30,000
Paid to lobbying firm
Coverage of obesity care. H.R.4231/S.1973 - Treat and Reduce Obesity Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION) · lobbying firm or registrant: ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Medicare/Medicaid
$106,603
Spent on own lobbying
Medical Nutrition Therapy Act (H.R.6199; S.3934) Expanding Access to Diabetes Self-Management Training Act (H.R.3826, S.1925) Treat and Reduce Obesity Act (H.R.4231/S.1973) Medically Tailored Home-Delivered Meals Demonstration Pilot Act (HR.5753, S.2834) CONNECT for Health Act (H.R. 4206/S. 1261)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANCE FOR PATIENT ACCESS · lobbying firm or registrant: ALLIANCE FOR PATIENT ACCESS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$20,000
Spent on own lobbying
S. 1973 / H.R. 4231 Treat and Reduce Obesity Act of 2025 S. 264 HELP Copays Act H.R.4317 - PBM Reform Act of 2025 COPD awareness/funding Biomarker testing coverage
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Pharmacy
$5,320,000
Spent on own lobbying
…vid - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contractin…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CURRAX PHARMACEUTICALS LLC · lobbying firm or registrant: DLA PIPER LLP (US)
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Pharmacy
$50,000
Paid to lobbying firm
Legislative and regulatory policies and proposals related to obesity treatment. Drug compounding safety. H.R. 4231/S. 1973, Treat and Reduce Obesity Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ELI LILLY AND COMPANY FKA LILLY USA, LLC · lobbying firm or registrant: FORBES-TATE
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 18, 2026 · issue area: Medicare/Medicaid
$50,000
Paid to lobbying firm
…edicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVO NORDISK, INC. · lobbying firm or registrant: ARNOLD & PORTER KAYE SCHOLER LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Medicare/Medicaid
$80,000
Paid to lobbying firm
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2025 (H.R. 4231 / S. 1973).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL KIDNEY FOUNDATION · lobbying firm or registrant: NATIONAL KIDNEY FOUNDATION
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Medicare/Medicaid
$100,000
Spent on own lobbying
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS · lobbying firm or registrant: MASON CONSULTING, LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 23, 2026 · issue area: Health Issues
$24,000
Paid to lobbying firm
…nnocence Act H.R. 3684, Save Americas Rural Hospitals Act of 2025 H.R. 3701, Family Vaccine Protection Act H.R. 3884/S. 2011, Telemental Health Care Access Act H.R. 4231/S. 1973, Treat and Reduce Obesity Act H.R. 4262, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) for Health Act H.R…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) · lobbying firm or registrant: AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Pharmacy
$4,120,000
Spent on own lobbying
…vid - Direct-to-consumer prescription advertising transparency H.R. 4139 - Cutting Copays Act - Rep. McGarvey, Morgan - Medicare cost-sharing for generic drugs H.R. 4231 - Treat and Reduce Obesity Act - Rep. Kelly, Mike - Medicare coverage of obesity drugs H.R. 4317 - PBM Reform Act - Rep. Carter, Earl L. Buddy - PBM contractin…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION) · lobbying firm or registrant: ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION)
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Medicare/Medicaid
$75,000
Spent on own lobbying
Medical Nutrition Therapy Act (H.R.6199) Expanding Access to Diabetes Self-Management Training Act (H.R.3826, S.1925) Treat and Reduce Obesity Act (H.R.4231/S.1973) Medically Tailored Home-Delivered Meals Demonstration Pilot Act (HR.5753, S.2834) Protect Patients Access to Telehealth: Support the Telehealth Moderni…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing